Global Transcatheter Aortic Valve Replacement (TAVR) Market Size, Status and Forecast 2020-2026

Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
The classification of Transcatheter Aortic Valve Replacement (TAVR) includes transfemoral approach, transapical approach and others. The proportion of transfemoral approach in 2017 is about 83%.
Transcatheter Aortic Valve Replacement (TAVR) is widely used for aortic stenosis, aortic regurgitation and other diseases. The most proportion of Transcatheter Aortic Valve Replacement (TAVR) is used for aortic regurgitation, and the proportion in 2017 is 76%.
Market Analysis and Insights: Global Transcatheter Aortic Valve Replacement (TAVR) Market
In 2019, the global Transcatheter Aortic Valve Replacement (TAVR) market size was US$ 3979.4 million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Transcatheter Aortic Valve Replacement (TAVR) Scope and Market Size
Transcatheter Aortic Valve Replacement (TAVR) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Transcatheter Aortic Valve Replacement (TAVR) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Transcatheter Aortic Valve Replacement (TAVR) market is segmented into Transfemoral Approach, Transapical Approach, Others, etc.
Segment by Application, the Transcatheter Aortic Valve Replacement (TAVR) market is segmented into Aortic Stenosis, Aortic Regurgitation, Others, etc.
Regional and Country-level Analysis
The Transcatheter Aortic Valve Replacement (TAVR) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Transcatheter Aortic Valve Replacement (TAVR) market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Transcatheter Aortic Valve Replacement (TAVR) Market Share Analysis
Transcatheter Aortic Valve Replacement (TAVR) market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Transcatheter Aortic Valve Replacement (TAVR) business, the date to enter into the Transcatheter Aortic Valve Replacement (TAVR) market, Transcatheter Aortic Valve Replacement (TAVR) product introduction, recent developments, etc.
The major vendors include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, etc.

This report focuses on the global Transcatheter Aortic Valve Replacement (TAVR) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Transcatheter Aortic Valve Replacement (TAVR) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Meril Life Sciences
...

Market segment by Type, the product can be split into

Transfemoral Approach
Transapical Approach
Others

Market segment by Application, split into

Aortic Stenosis
Aortic Regurgitation
Others

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Transcatheter Aortic Valve Replacement (TAVR) status, future forecast, growth opportunity, key market and key players.
To present the Transcatheter Aortic Valve Replacement (TAVR) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Transcatheter Aortic Valve Replacement (TAVR) are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions